SUNNYVALE, Calif.--(BUSINESS WIRE)--NTT Research, Inc., a division of NTT (TYO:9432), today announced that scientists from Tokyo Institute of Technology (Tokyo Tech) and NTT Research have successfully ...
Career Enrichment Opportunities at the Scientific Frontier in Radiation Oncology One substantial limitation of randomized clinical trials (RCTs) relates to the stringent eligibility criteria that are ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback